Carroll Investors’s HealthEquity HQY Stock Holding History

Carroll Investors’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-576	Closed	-$25K	–	188
2021 Q4	$25K	Buy	+576	New	+$33.5K	0.01%	126

Other funds holding HQY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Carroll Investors's HQY Position: Q1 2022 in Review

Carroll Investors sold out of HealthEquity (HQY) in Q1 2022, closing a stake of 576 shares — an estimated $25K sold.

Carroll Investors first reported a position in HQY in Q4 2021 and held it in 1 quarter. The position peaked at $25K in Q4 2021. 298 funds tracked by Wall St. Rank hold HQY as of Q1 2022.

Carroll Investors reported no remaining HealthEquity position as of Q1 2022 after selling out during the quarter.
Carroll Investors sold 576 HealthEquity shares in Q1 2022, an estimated $25K.
Carroll Investors first reported a position in HealthEquity in Q4 2021 and held it in 1 quarter.
Carroll Investors's HealthEquity position peaked at $25K in Q4 2021.
298 funds tracked by Wall St. Rank held HealthEquity as of Q1 2022.

Based on Carroll Investors's 13F filing for Q1 2022, filed 28 Apr 2022.